Therapeutic Targets Database
BIDD Pharmainformatics Databases


TTD Drug ID: DAP000877

Drug Information
SynonymsCanesten Extra Bifonazol; BRN 0618427; Bifonazol; Bioglan brand of bifonazole; EINECS 262-336-6; Spectrum2_000035; bifonazole; KBio3_002922; Moldina; STK618771; SMR000058970; 1-[phenyl-(4-phenylphenyl)methyl]imidazole; HMS2090K13; (+-)-1-(p,alpha-Diphenylbenzyl)imidazole; MLS000759537; Mycospor (TN); 1H-Imidazole, 1-((1,1'-biphenyl)-4-ylphenylmethyl)-, (+-)-; 60628-96-8; TL8003842; Bay-h-4502; Bifonazolum [INN-Latin]; LS-78073; MLS000028576; Trifonazole; Juventus brand of bifonazole; Bifonazol [INN-Spanish]; Inkeysa brand of bifonazole; SPECTRUM1505309; Bifonazolum; MolPort-003-666-632; Amycor; Bay H-4502; CHEBI:116973; Mycospor; BAY H 4502; Bio-0008; HMS1922B18; SAM001246775; Bifokey; MLS001074074; 1H-Imidazole, 1-((1,1'-biphenyl)-4-ylphenylmethyl)-; DB04794; CPD000058970; 1-(p,alpha-Diphenylbenzyl)imidazole; 5-23-04-00292 (Beilstein Handbook Reference); C036596; NCGC00089815-02; Spectrum3_001970; AC1L1DJN; Bifonazole (JP15/USAN/INN); BRD-A94543220-001-02-3; D01775; CHEMBL277535; NCGC00089815-03; HMS2051F04; 1H-Imidazole, 1-([1,1'-biphenyl]-4-ylphenylmethyl)-; Merck Lipha Sante brand of bifonazole; Azolmen; I01-2098; SPBio_000129; Bifon; CID2378; Dermapharm brand of bifonazole; NCGC00089815-04; Bifomyk; 1-((4-Biphenylyl)phenylmethyl)-1H-imidazole; 1-[4,alpha-Diphenylbenzyl]-imidazole; HMS2093B09; Bayer brand of bifonazole; 1-(alpha-(4-Biphenylyl)benzyl)imidazole; BSPBio_003570; Imidazole, 1-(alpha-(4-biphenylyl)benzyl)-; 1-[biphenyl-4-yl(phenyl)methyl]-1H-imidazole; C22H18N2; VU0239694-7; Canesten brand of bifonazole; AC-15414; (+-)1-([1,1'-Biphenyl]-4-ylphenylmethyl)-1H-imidazole; Bifonazole [USAN:BAN:INN:JAN]    
Trade NameCanespor    
CompanyBayer Pharmaceuticals Corporation    
IndicationFungal infectionsApproved    [1]

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
Therapeutic ClassAntifungal Agents    
CAS NumberCAS 60628-96-8
PubChem Compound IDCID 2378.    
PubChem Substance IDSID 183797.    
SuperDrug ATC IDD01AC10;    
SuperDrug CAS ID060628968;    
TargetCytochrome P450 51Inhibitor[2][3][4]
Ref 1Drug information of Bifonazole, 2008 To Reference
Ref 2Investigation of the role of cytochrome P450 2B4 active site residues in substrate metabolism based on crystal structures of the ligand-bound enzyme. Arch Biochem Biophys. 2006 Nov 1;455(1):61-7. Epub 2006 Sep 25. To Reference
Ref 3Bifonazole, a biochemist's view. Dermatologica. 1984;169 Suppl 1:3-9. To Reference
Ref 4Bifonazole and clotrimazole. Their mode of action and the possible reason for the fungicidal behaviour of bifonazole. Arzneimittelforschung. 1984;34(2):139-46. To Reference


Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.

Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore

All rights reserved.

Computer-aided Drug Design
About BIDD | Databases | Software | Teaching | Research |  Links

Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543